陈莉莉

Ye Wu, Rui Huang, Jin-Mei Jin, Li-Jun Zhang, Hong Zhang, Hong-Zhuan Chen, Li-Li Chen*, Xin Luan*. Advances in the Study of Structural Modification and Biological Activities of Anoplin. Front Chem. 2020, 8:519. (IF= 5.221)

Liqiang Ni^#, Lili Chen^#, Xia Huang^#, Chouping Han, Hong Zhang, Xin Luan, Yongfang Zhao, Jianguang Xu, Weian Yuan*, Hongzhuan Chen*. Combating COVID-19 with integrated traditional Chinese and Western medicine in China. Acta Pharm Sin B. 2020,10(7):1149-1162. (IF=11.413)

Shaopeng Yu^#, Yuying Zhu^#, Jiaruo Xu, Guangtao Yao, Pei Zhang, Mengge Wang, Yongfang Zhao, Guoqiang Lin, Hongzhuan Chen^*, Lili Chen^*, Jiange Zhang^*. Glycyrrhizic acid exerts inhibitory activity against the spike protein of SARS-CoV-2. Phytomedicine. 2021, 85:153364. (IF=5.34)

Yiming Yin, Mengge Wang, Wenjie Gu, Lili Chen*. Intestine-Specific FXR agonists as potential therapeutic agents for Colorectal Cancer. Biochem Pharmacol. 2021, 186:114430. (IF=5.858)

Ruyu Wang^#, Qing Hu^#, Haonan Wang, Guanghao Zhu, Mengge Wang, Qian Zhang, Yishu Zhao, Chunyu Li, Yani Zhang, Guangbo Ge^*,Hongzhuan Chen^*, Lili Chen^*. Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CL. Int J Biol Macromol, 2021, 183:182-192. (IF=6.953)

Yusen Xiang, Mengge Wang, Hongzhuan Chen*, Lili Chen*. Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2). Biochem Pharmacol. 2021, 192:114724. (IF=5.858)

Shaopeng Yu^#, Yao Chen^#, Yusen Xiang^#, He Lin, Mengge Wang, Wenbo Ye, Pei Zhang, Hongzhuan Chen, Guoqiang Lin, Yuying Zhu, Lili Chen^*, Jiange Zhang^*. Pseudoephedrine and its derivatives antagonize wild and mutated severe acute respiratory syndrome-CoV-2 viruses through blocking virus invasion and antiinflammatory effect. Phytother Res. 2021, 35(10):5847-5860. (IF=5.878)

Jiacheng Xiong^#, Yusen Xiang^#, Ziming Huang, Xiaohong Liu, Mengge Wang, Guangbo Ge, Hongzhuan Chen, Jianrong Xu^*, Mingyue Zheng^*, Lili Chen^*. Structure-based virtual screening and identification of potential inhibitors of SARS-CoV-2 S-RBD and ACE2 interaction, Front Chem. 2021, 9:740702. (IF= 5.221)

Guang-Hui Ma^#, Yan Ye^#, Dan Zhang^#, Xin Xu, Pei Si, Jian-Long Peng, Yong-Long Xiao, Rui-Yuan Cao, Yu-Ling Yin, Jing Chen, Lin-Xiang Zhao, Yu Zhou^*, Wu Zhong, Hong Liu, Xiao-Min Luo^*, Li-Li Chen^*, Xu Shen. Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening. Eur J Med Chem. 2016, 124:981-991. (IF= 4.519)

Xing Xu, Xin Xu, Peng Liu, Zhi-yuan Zhu, Jing Chen, Hai-an Fu, Li-li Chen^*, Li-hong Hu^*, Xu Shen^*. Structural Basis for Small Molecule NDB (N-Benzyl-N-(3-(tert-butyl)-4-hydroxyphenyl)-2,6-dichloro-4-(dimethylamino) Benzamide) as a Selective Antagonist of Farnesoid X Receptor α (FXRα) in Stabilizing the Homodimerization of the Receptor. J Biol Chem. 2015, 290(32):19888-99. (IF= 4.573)